Personalizovaná medicína: Translačním výzkumem k biomedicínským aplikacím
,
, 2023 - 2028
Genomic Data Infrastructure
,
, 2022 - 2026
Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu
(TE02000058),
Technologická agentura ČR, 2014 - 2019
APERIM - Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy
(633592),
Evropská unie, 2015 - 2018
Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia
(3SGA5792),
Jihomoravský kraj, 2013 - 2016
Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response
(NT11218),
Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia
(306242),
Evropská unie, 2012 - 2015
SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny
(CZ.1.07/2.3.00/20.0045),
Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
(MSM0021622430),
Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
Real-time PCR soupravy pro diagnostiku v onkologii
(FR-TI2/254),
Ministerstvo průmyslu a obchodu ČR, 2010 - 2013
Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases
(GAP301/10/0590),
Czech Science Foundation - Standard Grants, 2010 - 2012
Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development
(NS10439),
Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011
